Skip to menu Skip to content Skip to footer

2014

Journal Article

Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis

Smith, Daniel J., Hill, Geoffrey R., Bell, Scott C. and Reid, David W. (2014). Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis. PLoS ONE, 9 (10) e109891, 1-8. doi: 10.1371/journal.pone.0109891

Reduced mucosal associated invariant T-cells are associated with increased disease severity and Pseudomonas aeruginosa infection in cystic fibrosis

2014

Journal Article

Antimicrobial treatment of non-cystic fibrosis bronchiectasis

Grimwood, K., Bell, S.C. and Chang, A.B. (2014). Antimicrobial treatment of non-cystic fibrosis bronchiectasis. Expert Review of Anti-Infective Therapy, 12 (10), 1277-1296. doi: 10.1586/14787210.2014.952282

Antimicrobial treatment of non-cystic fibrosis bronchiectasis

2014

Journal Article

Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics

Smith, Daniel J., Badrick, Alison C., Zakrzewski, Martha, Krause, Lutz, Bell, Scott C., Anderson, Gregory J. and Reid, David W. (2014). Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics. European Respiratory Journal, 44 (4), 922-930. doi: 10.1183/09031936.00203013

Pyrosequencing reveals transient cystic fibrosis lung microbiome changes with intravenous antibiotics

2014

Journal Article

Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis

Knibbs, Luke D., Johnson, Graham R., Kidd, Timothy J., Cheney, Joyce, Grimwood, Keith, Kattenbelt, Jacqueline A., O'Rourke, Peter K., Ramsay, Kay A., Sly, Peter D., Wainwright, Claire E., Wood, Michelle E., Morawska, Lidia and Bell, Scott C. (2014). Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis. Thorax, 69 (8), 740-745. doi: 10.1136/thoraxjnl-2014-205213

Viability of Pseudomonas aeruginosa in cough aerosols generated by persons with cystic fibrosis

2014

Journal Article

A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosis

Syrmis, Melanie W., Kidd, Timothy J., Moser, Ralf J., Ramsay, Kay A., Gibson, Kristen M., Anuj, Snehal, Bell, Scott C., Wainwright, Claire E., Grimwood, Keith, Nissen, Michael, Sloots, Theo P. and Whiley, David M. (2014). A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosis. BMC Infectious Diseases, 14 (1) 307, 307.1-307.8. doi: 10.1186/1471-2334-14-307

A comparison of two informative SNP-based strategies for typing Pseudomonas aeruginosa isolates from patients with cystic fibrosis

2014

Journal Article

European Cystic Fibrosis Society standards of care: best practice guidelines

Smyth, A.R., Bell, S.C., Bojcin, S., Bryon, M., Duff, A., Flume, P., Kashirskaya, N., Munck, A., Ratjen, F., Schwarzenberg, S.J., Sermet-Gaudelus, I., Southern, K.W., Taccetti, G., Ullrich, G. and Wolfe, S. (2014). European Cystic Fibrosis Society standards of care: best practice guidelines. Journal of Cystic Fibrosis, 13 (S1), S23-S42. doi: 10.1016/j.jcf.2014.03.010

European Cystic Fibrosis Society standards of care: best practice guidelines

2014

Journal Article

Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity

Smith, Daniel J., Anderson, Gregory J., Bell, Scott C. and Reid, David W. (2014). Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity. Journal of Cystic Fibrosis, 13 (3), 289-295. doi: 10.1016/j.jcf.2013.12.001

Elevated metal concentrations in the CF airway correlate with cellular injury and disease severity

2014

Journal Article

Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire

Smith, Corey, Gras, Stephanie, Brennan, Rebekah M., Bird, Nicola L., Valkenburg, Sophie A., Twist, Kelly-Anne, Burrows, Jacqueline M., Miles, John J., Chambers, Daniel, Bell, Scott, Campbell, Scott, Kedzierska, Katherine, Burrows, Scott R., Rossjohn, Jamie and Khanna, Rajiv (2014). Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire. Scientific Reports, 4 (1) 3993, 3993.1-3993.10. doi: 10.1038/srep03993

Molecular imprint of exposure to naturally occurring genetic variants of human cytomegalovirus on the T cell repertoire

2014

Journal Article

Pregnancy and cystic fibrosis: approach to contemporary management

Geake, James, Tay, George, Callaway, Leonie and Bell, Scott C. (2014). Pregnancy and cystic fibrosis: approach to contemporary management. Obstetric Medicine, 7 (4), 147-155. doi: 10.1177/1753495X14554022

Pregnancy and cystic fibrosis: approach to contemporary management

2014

Journal Article

Challenges of providing care to adults with cystic fibrosis

Bell, Scott C. and Reid, David W. (2014). Challenges of providing care to adults with cystic fibrosis. European Respiratory Monograph, 64 (64), 286-303. doi: 10.1183/1025448x.10010513

Challenges of providing care to adults with cystic fibrosis

2014

Journal Article

A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: A phase 2 randomised controlled trial

Boyle, Michael P., Bell, Scott C., Konstan, Michael W., McColley, Susanna A., Rowe, Steven M., Rietschel, Ernst, Huang, Xiaohong, Waltz, David, Patel, Naimish R. and Rodman, David (2014). A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: A phase 2 randomised controlled trial. The Lancet Respiratory Medicine, 2 (7), 527-538. doi: 10.1016/S2213-2600(14)70132-8

A CFTR corrector (lumacaftor) and a CFTR potentiator (ivacaftor) for treatment of patients with cystic fibrosis who have a phe508del CFTR mutation: A phase 2 randomised controlled trial

2013

Journal Article

Change in the executive editorial team at JCF

Bell, Scott, Hartl, Dominik and Heijerman, Harry (2013). Change in the executive editorial team at JCF. Journal of Cystic Fibrosis, 12 (6), 545-546. doi: 10.1016/j.jcf.2013.10.006

Change in the executive editorial team at JCF

2013

Journal Article

Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis

Ramsay, Kay A., Butler, Claire A., Paynter, Stuart, Ware, Robert S., Kidd, Timothy J., Wainwright, Claire E. and Bell, Scott C. (2013). Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis. Journal of Clinical Microbiology, 51 (12), 3975-3980. doi: 10.1128/JCM.01360-13

Factors influencing acquisition of Burkholderia cepacia complex organisms in patients with cystic fibrosis

2013

Journal Article

Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation

Wood, Michelle E., Smith, Daniel J., Reid, David W., Masel, Philip J., France, Megan W. and Bell, Scott C. (2013). Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation. Respirology Case Reports, 1 (2), 52-54. doi: 10.1002/rcr2.27

Ivacaftor in severe cystic fibrosis lung disease and a G551D mutation

2013

Journal Article

Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection

Price E.P., Sarovich D.S., Mayo M., Tuanyok A., Drees K.P., Kaestli M., Beckstrom-Sternberg S.M., Babic-Sternberg J.S., Kidd T.J., Bell S.C., Keim P., Pearson T. and Currie B.J. (2013). Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection. mBio, 4 (4) e00388-13, e00388-13.1-e00388-13.11. doi: 10.1128/mBio.00388-13

Within-host evolution of Burkholderia pseudomallei over a twelve-year chronic carriage infection

2013

Journal Article

ICU outcomes in cystic fibrosis following invasive ventilation

Reid, David W. and Bell, Scott C. (2013). ICU outcomes in cystic fibrosis following invasive ventilation. Respirology, 18 (4), 585-586. doi: 10.1111/resp.12077

ICU outcomes in cystic fibrosis following invasive ventilation

2013

Journal Article

High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform

Syrmis, Melanie W., Moser, Ralf J., Kidd, Timothy J., Hunt, Priscilla, Ramsay, Kay A., Bell, Scott C., Wainwright, Claire E., Grimwood, Keith, Nissen, Michael D., Sloots, Theo P. and Whiley, David M. (2013). High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform. Journal of Medical Microbiology, 62 (5), 734-740. doi: 10.1099/jmm.0.055905-0

High-throughput single-nucleotide polymorphism-based typing of shared Pseudomonas aeruginosa strains in cystic fibrosis patients using the Sequenom iPLEX platform

2013

Journal Article

Management of comorbidities in older patients with cystic fibrosis

Plant, Barry J, Goss, Christopher H, Plant, William D and Bell, Scott C (2013). Management of comorbidities in older patients with cystic fibrosis. The Lancet Respiratory Medicine, 1 (2), 164-174. doi: 10.1016/S2213-2600(13)70025-0

Management of comorbidities in older patients with cystic fibrosis

2013

Journal Article

Screening bacterial metabolites for inhibitory effects against Batrachochytrium dendrobatidis using a spectrophotometric assay

Bell, Sara C., Alford, Ross A., Garland, Stephen, Padilla, Gabriel and Thomas, Annette D. (2013). Screening bacterial metabolites for inhibitory effects against Batrachochytrium dendrobatidis using a spectrophotometric assay. Diseases of Aquatic Organisms, 103 (1), 77-+. doi: 10.3354/dao02560

Screening bacterial metabolites for inhibitory effects against Batrachochytrium dendrobatidis using a spectrophotometric assay

2013

Journal Article

Aztreonam for inhalation solution, challenges to drug approval and integration into CF care

Goss, Christopher H. and Bell, Scott C. (2013). Aztreonam for inhalation solution, challenges to drug approval and integration into CF care. Journal of Cystic Fibrosis, 12 (2), 99-101. doi: 10.1016/j.jcf.2012.08.006

Aztreonam for inhalation solution, challenges to drug approval and integration into CF care